Olema Pharmaceuticals OLMA
NASDAQ OLMA
$8.23 -0.04 (-0.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

Olema Pharmaceuticals (OLMA) Cash & Equivalents (2020 - 2026)

Updated

Olema Pharmaceuticals (OLMA) reported Cash & Equivalents of $48.6 million for Q2 2026, down 7.4% from $52.47 million a year earlier and down 7.5% from the prior quarter.

Analysis

Olema Pharmaceuticals (OLMA) Cash & Equivalents (2020 - 2026) Analysis & Trends

At the end of FY2025, Olema Pharmaceuticals posted Cash & Equivalents of $48.3 million, down 65.4% from FY2024.

  • Cash & Equivalents has a five-year compound annual growth rate of -32.3% (FY2020 to FY2025).
  • By year, Cash & Equivalents came in at $139.48 million in FY2024 (+103.5%), $68.54 million in FY2023 (+189.2%), $23.7 million in FY2022 (+71.6%) and $13.81 million in FY2021 (-95.9%).
  • Five-year quarterly Cash & Equivalents spans a low of $13.81 million in Q4 2021 and a high of $139.48 million in Q4 2024.
  • Year over year, Cash & Equivalents gained in four of the last eight quarters, with growth averaging 28.0%.
  • The high point for year-over-year Cash & Equivalents in five years was Q3 2023 (growth of 338.0%); the low point was Q4 2021 (a decline of 95.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $52.55 million (Q1 2026), $48.3 million (Q4 2025) and $35.26 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.42 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 976.00 Mn
10 Olema Pharmaceuticals 719.73 Mn 719.73 Mn - 48.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 48.60 Mn
Mar 31, 2026 52.55 Mn
Dec 31, 2025 48.30 Mn
Sep 30, 2025 35.26 Mn
Jun 30, 2025 52.47 Mn
Mar 31, 2025 50.64 Mn
Dec 31, 2024 139.48 Mn
Sep 30, 2024 35.89 Mn
Jun 30, 2024 16.89 Mn
Mar 31, 2024 33.72 Mn
Dec 31, 2023 68.54 Mn
Sep 30, 2023 117.41 Mn
Jun 30, 2023 34.96 Mn
Mar 31, 2023 40.92 Mn
Dec 31, 2022 23.70 Mn
Sep 30, 2022 26.80 Mn
Jun 30, 2022 24.53 Mn
Mar 31, 2022 21.51 Mn
Dec 31, 2021 13.81 Mn
Sep 30, 2021 25.60 Mn
API Access

Olema Pharmaceuticals Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OLMA&period=max&api_key=YOUR_API_KEY